A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.
about
Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity.Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.Parathyroid Hormone (1-34) Might Not Improve Early Bone Healing after Sinus Augmentation in Healthy Rabbits.Influence of Dosing Interval and Administration on the Bone Metabolism, Skeletal Effects, and Clinical Efficacy of Parathyroid Hormone in Treating Osteoporosis: A Narrative Review
P2860
A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A systematic review on the use ...... igh risk for fracture in Asia.
@en
type
label
A systematic review on the use ...... igh risk for fracture in Asia.
@en
prefLabel
A systematic review on the use ...... igh risk for fracture in Asia.
@en
P2093
P2860
P1476
A systematic review on the use ...... igh risk for fracture in Asia.
@en
P2093
P2860
P2888
P356
10.1007/S00198-014-2838-7
P407
P577
2014-08-20T00:00:00Z
P5875
P6179
1014236649